Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Feb;148(2):291-4.
doi: 10.1053/j.gastro.2014.12.011. Epub 2014 Dec 18.

Long noncoding RNAs and hepatocellular carcinoma

Affiliations
Editorial

Long noncoding RNAs and hepatocellular carcinoma

James F Collins. Gastroenterology. 2015 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The author disclose no conflicts.

Figures

Figure 1.
Figure 1.
Pathologic regulatory pathway. Long noncoding RNA (lncRNA)-UFC1 is increased in hepatocellular carcinoma (HCC) samples from patients (upper left). UFC1 promotes translocation of the β-catenin transcript bound to HuR from the nucleus into the cytosol. Here, the UFC1/β-catenin/HuR complex stabilizes the β-catenin mRNA, leading to increased translation and production of β-catenin protein. Increased protein levels promote nuclear translocation, assisted by UFC1, where transcription of β-catenin target genes is enhanced (eg, c-myc, cyclin D1). The c-myc and cyclin D1 proteins (and perhaps others) then presumably lead to progression through the cell cycle, increasing cell proliferation, and also inhibit apoptosis of HCC cells. The overall effect then is tumor (and disease) progression. There is evidence that, under normal circumstances, lncRNA-UFC1 expression can be attenuated by microRNA (miRNA)-34a. Expression of this miRNA, is however, suppressed during HCC, allowing high lncRNA-UFC1 expression.

Comment on

References

    1. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009;136:629–641. - PubMed
    1. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009;23:1494–1504. - PMC - PubMed
    1. Zhang S, Lu Z, Unruh AK, et al. Clinically relevant microRNAs in ovarian cancer. Mol Cancer Res 2014. Oct 10 [Epub ahead of print]. - PMC - PubMed
    1. Rachagani S, Macha MA, Heimann N, et al. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Adv Drug Deliv Rev 2014. Oct 23 [Epub ahead of print]. - PMC - PubMed
    1. Fang XY, Pan HF, Leng RX, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett 2015; 356:357–366. - PubMed